Mercer Global Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-16,478
| Closed | -$3.03M | – | 1846 |
|
|
2021
Q2 | $3.03M | Sell |
16,478
-6,632
| -29% | -$1.22M | 0.02% | 446 |
|
|
2021
Q1 | $3.53M | Sell |
23,110
-1,585
| -6% | -$242K | 0.03% | 380 |
|
|
2020
Q4 | $3.86M | Buy |
24,695
+2,080
| +9% | +$325K | 0.05% | 268 |
|
|
2020
Q3 | $2.59M | Sell |
22,615
-1,117
| -5% | -$128K | 0.04% | 318 |
|
|
2020
Q2 | $2.66M | Buy |
23,732
+3,275
| +16% | +$368K | 0.05% | 269 |
|
|
2020
Q1 | $1.84M | Buy |
20,457
+18,582
| +991% | +$1.67M | 0.04% | 333 |
|
|
2019
Q4 | $203K | Buy |
+1,875
| New | +$203K | ﹤0.01% | 1080 |
|
|
2019
Q3 | – | Sell |
-1,530
| Closed | -$200K | – | 1219 |
|
|
2019
Q2 | $200K | Sell |
1,530
-62
| -4% | -$8.11K | 0.01% | 1056 |
|
|
2019
Q1 | $215K | Buy |
+1,592
| New | +$215K | 0.01% | 964 |
|